Assessment of Efficacy, Safety, and Quality of Life of 124 Patients Treated With Axitinib as Second-Line Therapy for Metastatic Renal-Cell Carcinoma: Experience in Real-World Clinical Practice in Japan
- Resource Type
- Article
- Source
- In
Clinical Genitourinary Cancer February 2017 15(1):122-128 - Subject
- Language
- ISSN
- 1558-7673